LIVE DATABASE v1.0
返回公司目录
COMPANY PROFILE / #1918

Fathom Therapeutics

New York, NYVenture Capital-Backed
官网
OVERVIEW

Developer of a computational molecular design system intended for drug discovery and therapeutic development. The company's platform combines physics-based simulations, machine learning models, and high-performance computing to generate and evaluate molecular designs, simulate protein-protein interactions, predict binding affinities, and optimize therapeutic degraders, enabling pharmaceutical researchers and biotech companies to identify novel drug candidates, accelerate discovery timelines, and reduce development costs for previously intractable biological targets.

已融资54.08
最新估值120.00
员工数7
成立年份2023

公司概况

Companies
Fathom Therapeutics
Description
Developer of a computational molecular design system intended for drug discovery and therapeutic development. The company's platform combines physics-based simulations, machine learning models, and high-performance computing to generate and evaluate molecular designs, simulate protein-protein interactions, predict binding affinities, and optimize therapeutic degraders, enabling pharmaceutical researchers and biotech companies to identify novel drug candidates, accelerate discovery timelines, and reduce development costs for previously intractable biological targets.
HQ Location
New York, NY
Year Founded
2023
Keywords
drug candidates discovery, drug candidates testing, medicine discovery, protein discovery, protein research, protein study
Competitors
Ownership Status
Privately Held (backing)
Company Financing Status
Venture Capital-Backed

融资与估值

Total Raised
54.08
First Financing Date
15-Nov-2023
First Financing Size
7.08
First Financing Valuation
33.00
Last Financing Date
27-Apr-2026
Last Financing Deal Type
Early Stage VC
Last Financing Size
47.00
Last Financing Valuation
120.00
Last Financing Status
Completed
Last Known Valuation
120.00
Last Known Valuation Date
27-Apr-2026
Last Known Valuation Deal Type
Early Stage VC
Valuation Estimate
153.66
Valuation Estimate Growth Rate
28.05%
Active Investors
8VC, Alexandria Venture Investments, Chemistry Ventures, JAZZ Venture Partners, New Leaf Venture, New York Venture Partners, Prime Movers Lab, Sutter Hill Ventures
# Active Investors
8
Acquirers

团队与联系人

Employees
7
Employee Growth %
Employee History
2024: 7
Primary Contact
Huafeng Xu
Primary Contact Title
Co-Founder, Chief Executive Officer & Board Member
Primary Contact Email
huafeng@atommap.com
Primary Contact Phone
+1 (917) 968-8176

增长与经营

Revenue
Revenue Growth %
Growth Rate
0.00%
Growth Rate % Change
Growth Rate Percentile
13
Size Multiple
3.46x
Size Multiple % Change
Size Multiple Change
Size Multiple Percentile
76
Majestic Referring Domains
90
SimilarWeb Unique Visitors
SimilarWeb Unique Visitors Change
SimilarWeb Growth Rate
SimilarWeb Growth Rate Percentile
Success Probability Over Time – 1 Year
10%
Success Probability Over Time – 3 Year
25%
Success Probability Over Time – 5 Year
37%
记录来源:public.companies · 原始序号 #1918 · 所有字段均按数据库原值展示。